Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple MyelomaStephen Schey, Angus Dalgleish, J. Blake Bartlett et al.|Journal of Clinical Oncology|2004Cited by 315